| Science and Policy Advisors Scientific Advisor Edward J. Cone, Ph.D. joined Pinney Associates to lead development of novel drug delivery systems for the pharmaceutical industry after his retirement from the U.S. Public Health Service (PHS) in 1998.
Recognized world-wide for his expertise on the chemistry and pharmacology of drugs of abuse, Ed has published over 250 research and... Scientific Consultant Karen L. Sees, D.O., began consulting with Pinney Associates in 2000. She has over 21 years experience in substance abuse treatment, research, and pain management, with a particular emphasis on innovative treatment of opioid and nicotine dependence.
Previously, Karen served as a Clinical Instructor in the Department of Psychiatry... Senior Advisor
George Quesnelle joined PinneyAssociates following his retirement from GlaxoSmithKline (GSK) Consumer Healthcare after 30 years in the pharmaceutical and consumer healthcare products industries. Throughout his 30 years, he held positions in sales, sales management, marketing, marketing management and general management.
While... Scientific Advisor Nabarun Dasgupta, MPH is a quantitative epidemiologist who studies the use and nonmedical use of prescription opioid pain relievers and heroin. He has worked with and for diverse groups on reducing the adverse consequences of opioid use, including at the World Health Organization, non-profit organizations, local health departments, and the... |
|
